Product Name | Miglustat Hydrochloride (N-Butyldeoxynojirimycin Hydrochloride; NB-DNJ hydrochloride; OGT918 hydrochloride) |
---|---|
CAS | 210110-90-0 |
Formula | C10H21NO4.HCl |
MW | 255.74 |
Appearance | White to light brown |
Storage condition | Dry, dark and at 0 - 4℃ for short term (days to weeks) or -20℃ for long term (months to years). |
Miglustat, also known as OGT 918 and NB-DNJ, is a drug developed by Actelion and is used primarily to treat Type I Gaucher disease (GD1). Miglustat inhibits glucosylceramide synthase, an essential enzyme for the synthesis of most glycosphingolipids (it forms glucosylceramide and accumulates within the macrophages).
© Copyright 2015-2021 Chemleader Biomedical Co., Ltd. All Rights Reserved.
沪ICP备15046197号-4
沪公网安备31011502007856号
Designed by Kuanersoft